Angelika Vlachou
Angel Investor @ HTGF (High-Tech Gruenderfonds)
Berlin, Germany
Angelika Vlachou is a seed investor at HTGF (High-Tech Gruenderfonds) in Berlin focused on Biotechnology and Genetics. Senior Investment Manager with Brandenburg Kapital since 2019 and management of the life science portfolio. Over ten years of experience in venture investing in the healthcare area. Actively manages investments in bio-pharma, especially drug development in neurodegenerative, chronic inflammatory, oncology, autoimmune diseases, deliverytechnologies etc. Prior strategy manager with biopharmaceutical company. She has successfully executed numerous private placements, trade sales, IPOs and licensing transactions in Europe and the U.S. Board member of Lipocalyx and board observer to Immunic Therapeutics. Angelika holds a doctorate in molecular biology from the Institut für Medizinische Virologie at the Universität of Gießen, where she graduated "summa cum laude" and a MBA degree from Potsdam University.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Angelika Vlachou invests in
Stages Angelika Vlachou invests in
Countries Angelika Vlachou invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (33%)
- Genetics 1 (17%)
- Oncology 1 (17%)
- Software 1 (17%)
- Biopharma 1 (17%)
Stage
- Seed 3 (50%)
- Funding Round 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. | Seed / Jun 30, 2026 | ||
| smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. | $5.5M / Seed / Oct 22, 2025 | ||
| SRTD Biotech is an RNA-based biotechnology company that focuses on oncology, infectious, and genetic disorders. | Seed / Nov 14, 2024 | ||
| mediaire GmbH is a software for computer-based diagnosis in radiology was developed, which is locally installed | $12.7M / Nov 13, 2024 | ||
| smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. | $1.3M / Seed / May 23, 2023 | ||
| faCellitate develops polymeric platforms that aim at supporting cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The platform facilitates cellular interaction, significantly improving cell culture in biological research. | $3.7M / Seed / Sep 07, 2022 |
Co-Investors
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.
HTGF (High-Tech Gruenderfonds) Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alexander Hölz
Investment Controller
|
|||
Cornelia Klug
Marketing & Communications
|
|||
Irina Gerlach
Head of Office
|
|||
Kristin Müller
Investment Manager
|
|||
Lena Krzyzak
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Angelika Vlachou invest in?
Angelika Vlachou invests primarily in Biotechnology, Genetics and Oncology startups, most often at Seed and Funding Round stage. Most of the 6 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Angelika Vlachou?
Public channels for Angelika Vlachou include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Angelika Vlachou last invest?
The most recent investment recorded for Angelika Vlachou closed in Jun 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
